(Reuters) – AstraZeneca (NASDAQ:AZN) Plc’s head of oncology research, Jose Baselga, has died at the age of 61, the company said on Sunday.
“An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca,” the company’s Chief Executive Officer Pascal Soriot said https:// in a statement.
The statement did not give a cause of death but Spanish newspaper La Vanguardia said Baselga had died of Creutzfeldt-Jakob disease, a rare brain condition.
Baselga joined AstraZeneca in 2019. He previously worked as Memorial Sloan Kettering Cancer Center’s chief medical officer. He had also been chief of hematology/oncology at the Massachusetts General Hospital Cancer Center and a professor at Harvard Medical School.
AstraZeneca’s head of R&D for oncology dies at 61
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.